A detailed history of Private Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Private Capital Management LLC holds 1,076 shares of AMGN stock, worth $340,016. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,076
Previous 1,094 1.65%
Holding current value
$340,016
Previous $311,000 8.04%
% of portfolio
0.06%
Previous 0.06%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

SELL
$262.75 - $319.31 $4,729 - $5,747
-18 Reduced 1.65%
1,076 $336,000
Q1 2024

Apr 10, 2024

BUY
$268.87 - $324.56 $14,250 - $17,201
53 Added 5.09%
1,094 $311,000
Q4 2023

Jan 09, 2024

BUY
$255.7 - $288.46 $7,671 - $8,653
30 Added 2.97%
1,041 $299,000
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $221,055 - $274,446
1,011 New
1,011 $271,000
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $13,095 - $15,961
58 Added 2.91%
2,050 $495,000
Q4 2022

Jan 30, 2023

BUY
$229.03 - $291.01 $3,435 - $4,365
15 Added 0.76%
1,992 $523,000
Q3 2022

Nov 03, 2022

BUY
$224.46 - $253.15 $3,142 - $3,544
14 Added 0.71%
1,977 $446,000
Q1 2022

Apr 20, 2022

BUY
$219.27 - $242.57 $37,495 - $41,479
171 Added 9.54%
1,963 $475,000
Q4 2021

Jan 12, 2022

BUY
$198.88 - $227.6 $15,910 - $18,208
80 Added 4.67%
1,792 $403,000
Q3 2021

Oct 12, 2021

BUY
$212.27 - $248.7 $16,769 - $19,647
79 Added 4.84%
1,712 $364,000
Q2 2021

Jul 22, 2021

BUY
$233.58 - $259.14 $2,802 - $3,109
12 Added 0.74%
1,633 $398,000
Q1 2021

Apr 14, 2021

BUY
$221.91 - $258.6 $3,106 - $3,620
14 Added 0.87%
1,621 $403,000
Q4 2020

Jan 15, 2021

SELL
$216.38 - $257.67 $9,304 - $11,079
-43 Reduced 2.61%
1,607 $365,000
Q2 2020

Jul 08, 2020

BUY
$197.81 - $242.74 $326,188 - $400,278
1,649 Added 164900.0%
1,650 $389,000
Q2 2020

Jul 08, 2020

SELL
$197.81 - $242.74 $326,188 - $400,278
-1,649 Reduced 99.94%
1 $389,000
Q4 2018

May 30, 2019

BUY
$178.4 - $208.25 $294,360 - $343,612
1,650 New
1,650 $321,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Private Capital Management LLC Portfolio

Follow Private Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Management LLC with notifications on news.